DIPB vs. SIFIB for Postoperative Analgesia After Hip Surgery
This study compares two different nerve block techniques used to reduce pain after hip replacement surgery. Both techniques numb the area around the hip to help manage postoperative pain, and this trial will determine which method works better for pain control.
Key Objective: The trial is testing which nerve block technique provides better pain relief and faster recovery after hip replacement surgery.
Who to Consider: Patients scheduled for primary total hip replacement surgery who want to explore advanced pain management options should consider enrolling.
Trial Parameters
Brief Summary
This randomized, double-blind clinical trial aims to compare the effectiveness of the Deep Iliacus Plane Block (DIPB) and the Suprainguinal Fascia Iliaca Block (SIFIB) for postoperative pain control in patients undergoing primary total hip arthroplasty. Effective analgesia after hip surgery is essential for early mobilization, reduction of complications, and improved recovery outcomes. Seventy patients scheduled for elective hip arthroplasty under spinal anesthesia will be randomly assigned to receive either DIPB or SIFIB at the end of surgery. Postoperative pain scores, opioid consumption, motor block, and block-related complications will be evaluated over a 48-hour period. The study aims to determine whether DIPB provides superior or comparable analgesia with reduced motor blockade compared to SIFIB, thereby contributing to safer and more comprehensive postoperative pain management in hip surgery patients.
Eligibility Criteria
Inclusion Criteria: * Patients aged ≥18 years * ASA physical status I-III * Scheduled for elective primary total hip arthroplasty under spinal anesthesia * Ability to understand the study procedures and provide informed consent Exclusion Criteria: * Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia * Infection at the block application site * Hemodynamic instability * Known allergy to local anesthetics * Pre-existing significant neurological or motor deficits in the lower extremities * Cognitive impairment preventing pain assessment * Refusal to participate or inability to provide informed consent